FAPI PET/CT 对肺癌患者淋巴结转移的诊断效能:一项 Meta 分析
该 Meta 分析纳入 7 项研究共 409 例患者,评估 FAPI PET/CT 诊断肺癌淋巴结转移的效能。汇总敏感度 88%、特异度 94%、AUC 0.97;6 项头对头研究显示 FAPI PET/CT 优于 FDG PET/CT(敏感度 89% vs 78%,特异度 94% vs 66%,AUC 0.97 vs 0.80)。FAPI PET/CT 阴性排除效能突出,可能减少有创诊断操作。
要点
- FAPI PET/CT 诊断肺癌淋巴结转移汇总敏感度 88%、特异度 94%、AUC 0.97。
- 头对头比较中 FAPI PET/CT 敏感度 89% 优于 FDG PET/CT 的 78%。
- FAPI PET/CT 特异度 94% 优于 FDG PET/CT 的 66%。
核心结论
- FAPI PET/CT 对肺癌患者淋巴结转移检测显示出优异的诊断准确度,并优于标准诊疗中使用的 FDG PET/CT。
- FAPI PET/CT 对淋巴结转移的突出阴性排除效能提示其具有减少有创诊断操作的潜力。
研究设计与样本
- 研究类型为 Meta 分析,检索 PubMed 和 Embase 数据库截至 2024 年 7 月发表的相关文献。
- 纳入报告 FAPI PET/CT 检测肺癌患者淋巴结转移诊断准确度的研究,共纳入 7 项研究、409 例患者。
- 在可获得数据的研究中进行 FAPI PET/CT 与氟代脱氧葡萄糖(FDG)PET/CT 的头对头比较,共 6 项研究提供头对头比较数据。
- 采用双变量随机效应模型确定汇总敏感度、特异度和综合受试者工作特征曲线下面积(AUC)。
诊断标准与关键数值
- FAPI PET/CT 检测肺癌淋巴结转移的汇总敏感度为 88%(95%CI,78-93%),特异度为 94%(95%CI,89-96%),AUC 为 0.97(95%CI,0.95-0.98)。
- 头对头比较中,FAPI PET/CT 的汇总敏感度为 89%(95%CI 80-95%),特异度为 94%(95%CI 89-97%),AUC 为 0.97(95%CI 0.95-0.98)。
- 头对头比较中,FDG PET/CT 的汇总敏感度为 78%(95%CI 64-87%),特异度为 66%(95%CI 33-88%),AUC 为 0.80(95%CI 0.76-0.83)。
- Fagan 列线图显示,当验前概率设为 26% 时,FAPI PET/CT 扫描的阴性验后概率可降至 4%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the diagnostic performance of fibroblast activation protein inhibitors (FAPI) PET/CT for the detection of lymph node (LN) metastases in lung cancer patients.
METHODS: The PubMed and Embase databases were searched to identify relevant articles published through July 2024. We included studies reporting the diagnostic accuracy of FAPI PET/CT in detecting LN metastases in lung cancer patients. A head-to-head comparison of FAPI PET/CT and fluorodeoxyglucose (FDG) PET/CT was made among available studies. The pooled sensitivity, specificity, and area under the summary receiver-operating characteristics curve (AUC) were determined by using bivariate random-effects model.
RESULTS: Seven studies with 409 patients were eligible. The pooled sensitivity, specificity, and AUC value for FAPI PET/CT in detecting LN metastases in lung cancer patients were 88% (95% CI, 78-93%), 94% (95% CI, 89-96%), and 0.97 (95% CI, 0.95-0.98), respectively. Six studies provided head-to-head comparison data, and the pooled sensitivity, specificity, and AUC value were 89% (95% CI 80-95%), 94% (95% CI 89-97%), and 0.97 (95% CI 0.95-0.98) for FAPI PET/CT versus 78% (95% CI 64-87%), 66% (95% CI 33-88%), and 0.80 (95% CI 0.76-0.83) for FDG PET/CT. Fagan nomogram indicated that when the pre-test probability was set at 26%, the negative post-test probability for a FAPI PET/CT scan could decrease to 4%.
CONCLUSIONS: FAPI PET/CT shows excellent diagnostic accuracy for the detection of LN metastases in lung cancer patients, and is superior to standard-of-care FDG PET/CT. The outstanding ruling-out performance of FAPI PET/CT for LN metastases indicates that it holds the potential to reduce invasive diagnostic procedures.
引用
- Wan QC, Bai L, Wang ZY, et al. Diagnostic Performance of FAPI PET/CT for the Detection of Lymph Node Metastases in Lung Cancer Patients: A Meta-analysis. Acad Radiol. 2024. PMID: 39406578. doi:10.1016/j.acra.2024.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。